Gestation need not be discouraged in pati ents with spinal cord lesions.1.2 As a result pregnancy may now be possible for pre viously spastic women, in whom the ser iously disabling spastic features are sup pressed by intrathecal baclofen infusion. 3 We are reporting a pregnancy in a quadrip legic patient treated with continuous intra thecal baclofen infusion to manage her severe spasticity.
Case report
The intractable spasticity (maximum values of Ashworth-( =5), spasm-( =4) and clonus scale (=5)) in a 29 year old quadriplegic (since 1983) patient, gravida 1, para 0, with an incomplete cervical C6-7 spinal cord lesion following disci tis after discography, was successfully treated with a high dose of 1000 mcg/24 h continuous intrathecal ba clofen administration using an implanted drug delivery system (Synchromed(R), Med tronic, USA). The prolonged extended im provement of her disability (spasticity scales respectively 1, 0 and 1) and the lack of side effects from the intrathecal baclofen therapy were the reasons for the spouses' wish for children. After 15 months of baclofen treat ment she became pregnant after ovulation stimulation with clomiphene. With a gradual increase of the intrathecal baclofen dose (1100 mcg/24 h) spasticity could be fairly well controlled. She was hospitalised in the 32nd week. At that time premature uterine contractions and concomitant mild spastic features arose (spasticity scales 1, 4 and 2) which again could be controlled by a further increase of the baclofen (1200 mcg/24 h). Uterine contractions were suppressed by an intravenous infusion of fenoterol (1.4 mg/24 h). Cardiotocogram, placental hormones, blood flow velocity in the umbilical cord and ultrasound examina tion were normal. However in the 35th week spasticity could no longer be con trolled by dose increments (up to 1400 mcg/24 h). Even with maximum values of the spasticity scales we could not classify the evoked spastic symptoms. Continuous muscular contractions of the legs, severe flexor and abdominal muscle spasms, pilo erection, sweating, headache, fluctuations of blood pressure (120/85 to 180/110) and heart rate (70 to 110 beats/min) related to the severe paroxysmal abdominal muscle contractions occurred. 4 With continuous epidurally infused bupivacaine (11.25 mg/h) 1,5 adequate relaxation could be reached. The severe spasticity associated with symptoms of autonomic dysregula tion 1.2,4-9 was the reason for considering termination of gestation. After assessment of foetal pulmonary maturity (amniotic fluid lecithin/sphingomyelin (L/S) ratio> 2), we carried out a primary caesarean section under epidural bupivacaine anaesthesia. A healthy girl was born (2040 g, Apgar 9 and 10). Postoperatively spasticity could again be effectively managed.
Discussion
With the new treatment of continuous intra thecal baclofen infusion, gestation is now possible in patients with a high spinal cord lesion associated with severe spasticity. However, our patient demonstrated that painful visceral stimulation below the leReferences sion, like mild uterine contractions, evokes enormous spastic symptoms, as well as potentially life threating autonomic dys regulation 1.9, which were insufficiently con trolled by intrathecal baclofen infusion. The fact that postoperatively spasticity was again easily managed indicates that recurrence of the spastic symptoms was caused by break through in the intrathecal baclofen therapy.
